Position in INVA
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$6,364,250
-$102,245 QoQ
Shares Held
280,240
+1.0% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#43
of 307 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CX Institutional holds $30,767,447 across 22 Biotechnology names. INVA ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
|
259,496 | $9,448,249 | |
| 2 | INVA |
Innoviva, Inc.
This page
|
280,240 | $6,364,250 | |
| 3 | INCY |
Incyte Corp
|
48,034 | $5,445,134 | |
| 4 | EXEL |
Exelixis, Inc.
|
91,216 | $4,963,062 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
9,216 | $2,220,779 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,838 | $912,989 | |
| 7 | MRNA |
Moderna, Inc.
|
8,720 | $610,661 | |
| 8 | TECH |
BIO-TECHNE Corp
|
4,807 | $339,614 |
All Filings in INVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,364,250 | 280,240 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $6,466,495 | 277,532 | Shares | Sole | 2026-04-06 | |
| No filing history on record for this holder in this stock. | ||||||